Hints and tips:
...“I’ve now taken the Myers-Briggs assessment twice, for business, and what I’ve learned is that I am a total introvert,” she says. “That’s my real self. I’ve always been a pretend extrovert....
...This was classic streets versus the establishment.” — Paul Myers, Corona del Mar, California...
...Barbara Young tuts as she points to a chart on her wall showing recent disease trends for four of the UK’s most important diseases....
...We visited Bristol Myer Squibb (where Renaud Sermondade gave us a captivating presentation and described the challenges of working in a market where there are no intellectual property rights and generic...
...Barbara Ryan, research analyst at Deutsche Bank, believes Pfizer, Merck and BMS are all well positioned to make transforming acquisitions....
...“The case for mergers in the pharmaceutical industry can be convincingly and unequivocally made at the current time,” say Deutsche Bank analysts Barbara Ryan and George Drivas in a recent report....
...Bristol-Myers Squibb’s new chief executive on Thursday began to put his stamp on the US drugmaker by pledging job cuts and facility closures to accelerate profit growth....
...Barbara Ryan, analyst at Deutsche Bank, said: “Bristol-Myers obviously could not lure an external candidate and we view this as a purely cosmetic move …The outlook for Bristol remains unchanged in our view...
...The damage to Bristol’s profits could force it to slash its dividend from $1.12 to 60 cents, according to Barbara Ryan, analyst at Deutsche Bank....
...Bristol-Myers Squibb, Eli Lilly, Merck, Pfizer, Schering-Plough and Wyeth posted lower margins last year....
International Edition